Cargando…
A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia
BACKGROUND: The causative pathogens of and prevalence of antibiotic resistance in community-acquired pneumonia (CAP) varies across countries. We evaluated the patterns of antibiotic prescriptions for adult CAP patients, and physician satisfaction with the form and content of the 2009 Korean CAP trea...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902813/ https://www.ncbi.nlm.nih.gov/pubmed/24475353 http://dx.doi.org/10.3947/ic.2013.45.4.394 |
_version_ | 1782301034838753280 |
---|---|
author | Kim, Hye-In Kim, Shin-Woo Chang, Hyun-Ha Lee, Jong-Myung Peck, Kyong Ran |
author_facet | Kim, Hye-In Kim, Shin-Woo Chang, Hyun-Ha Lee, Jong-Myung Peck, Kyong Ran |
author_sort | Kim, Hye-In |
collection | PubMed |
description | BACKGROUND: The causative pathogens of and prevalence of antibiotic resistance in community-acquired pneumonia (CAP) varies across countries. We evaluated the patterns of antibiotic prescriptions for adult CAP patients, and physician satisfaction with the form and content of the 2009 Korean CAP treatment guidelines. MATERIALS AND METHODS: We designed an online survey for clinical physicians who treat CAP (infectious disease specialists, pulmonologists, and other physicians). We e-mailed the online survey to physicians and gathered results from December 2011 to January 2012, and then analyzed their responses. RESULTS: A total of 157 physicians responded to our survey: 61 (38.9%) infectious disease specialists, 33 (21.0%) pulmonologists, and 63 (40.1%) other physicians. Two-thirds (96/157, 61.2%) had positions in tertiary and secondary hospitals; the others (61, 38.8%) worked in primary clinics (hospitals and private clinics). One hundred and eight (68.8%) were aware of the Korean CAP clinical guidelines; of these, 98 (62.4%) applied the guidelines to their practice. Among physicians using them, 86.7% (85/98) reported the guidelines to be most useful for empirical selection of antibiotics, and 75.2% (118/157) said the guidelines were useful and satisfactory. Sixty-eight (43.3%) respondents indicated that they had not used aminoglycosides as an initial empirical CAP treatment, while 51 (32.5%) had combined aminoglycosides with other antibiotics to treat patients with CAP. Seventy-three (46.5%) physicians often combined macrolides with β-lactam antibiotics for empirical treatment of CAP, and 21 (13.4%) reported using macrolide monotherapy (which is not recommended in the 2009 Korean CAP treatment guidelines) for CAP patients. The most commonly used β-lactams were third-generation cephalosporins (72, 45.9%) and ampicillin/sulbactam or amoxicillin/clavulanate (28, 17.8%). CONCLUSIONS: Some physicians remain unaware of the 2009 Korean treatment guidelines for CAP and do not use them in clinical practice. In addition, aminoglycoside combination therapy is frequently and inappropriately used in practice. In some cases, CAP is treated with macrolide monotherapy. Thus, the Korean CAP clinical guidelines must be more aggressively and continuously publicized. |
format | Online Article Text |
id | pubmed-3902813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | The Korean Society of Infectious Diseases and Korean Society for Chemotherapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-39028132014-01-28 A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia Kim, Hye-In Kim, Shin-Woo Chang, Hyun-Ha Lee, Jong-Myung Peck, Kyong Ran Infect Chemother Original Article BACKGROUND: The causative pathogens of and prevalence of antibiotic resistance in community-acquired pneumonia (CAP) varies across countries. We evaluated the patterns of antibiotic prescriptions for adult CAP patients, and physician satisfaction with the form and content of the 2009 Korean CAP treatment guidelines. MATERIALS AND METHODS: We designed an online survey for clinical physicians who treat CAP (infectious disease specialists, pulmonologists, and other physicians). We e-mailed the online survey to physicians and gathered results from December 2011 to January 2012, and then analyzed their responses. RESULTS: A total of 157 physicians responded to our survey: 61 (38.9%) infectious disease specialists, 33 (21.0%) pulmonologists, and 63 (40.1%) other physicians. Two-thirds (96/157, 61.2%) had positions in tertiary and secondary hospitals; the others (61, 38.8%) worked in primary clinics (hospitals and private clinics). One hundred and eight (68.8%) were aware of the Korean CAP clinical guidelines; of these, 98 (62.4%) applied the guidelines to their practice. Among physicians using them, 86.7% (85/98) reported the guidelines to be most useful for empirical selection of antibiotics, and 75.2% (118/157) said the guidelines were useful and satisfactory. Sixty-eight (43.3%) respondents indicated that they had not used aminoglycosides as an initial empirical CAP treatment, while 51 (32.5%) had combined aminoglycosides with other antibiotics to treat patients with CAP. Seventy-three (46.5%) physicians often combined macrolides with β-lactam antibiotics for empirical treatment of CAP, and 21 (13.4%) reported using macrolide monotherapy (which is not recommended in the 2009 Korean CAP treatment guidelines) for CAP patients. The most commonly used β-lactams were third-generation cephalosporins (72, 45.9%) and ampicillin/sulbactam or amoxicillin/clavulanate (28, 17.8%). CONCLUSIONS: Some physicians remain unaware of the 2009 Korean treatment guidelines for CAP and do not use them in clinical practice. In addition, aminoglycoside combination therapy is frequently and inappropriately used in practice. In some cases, CAP is treated with macrolide monotherapy. Thus, the Korean CAP clinical guidelines must be more aggressively and continuously publicized. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2013-12 2013-12-27 /pmc/articles/PMC3902813/ /pubmed/24475353 http://dx.doi.org/10.3947/ic.2013.45.4.394 Text en Copyright © 2013 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Hye-In Kim, Shin-Woo Chang, Hyun-Ha Lee, Jong-Myung Peck, Kyong Ran A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia |
title | A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia |
title_full | A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia |
title_fullStr | A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia |
title_full_unstemmed | A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia |
title_short | A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia |
title_sort | 2011-2012 survey of doctors' perceptions of korean guidelines and empirical treatment of community-acquired pneumonia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902813/ https://www.ncbi.nlm.nih.gov/pubmed/24475353 http://dx.doi.org/10.3947/ic.2013.45.4.394 |
work_keys_str_mv | AT kimhyein a20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT kimshinwoo a20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT changhyunha a20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT leejongmyung a20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT peckkyongran a20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT kimhyein 20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT kimshinwoo 20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT changhyunha 20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT leejongmyung 20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia AT peckkyongran 20112012surveyofdoctorsperceptionsofkoreanguidelinesandempiricaltreatmentofcommunityacquiredpneumonia |